Can Extended Chemotherapy Improve Glioblastoma Outcomes? A Retrospective Analysis of Survival in Real-World Patients.

Gherasim-Morogai, Natalia; Afrasanie, Vlad-Adrian; Gafton, Bogdan; Marinca, Mihai Vasile; Alexa-Stratulat, Teodora

Gherasim-Morogai, Natalia; Afrasanie, Vlad-Adrian; Gafton, Bogdan; Marinca, Mihai Vasile; Alexa-Stratulat, Teodora.

Afiliación

Gherasim-Morogai N; Medical Oncology Department, Regional Institute of Oncology, 700483 Iasi, Romania.
Afrasanie VA; Medical Oncology Department, Regional Institute of Oncology, 700483 Iasi, Romania.
Gafton B; Medical Oncology Department, Regional Institute of Oncology, 700483 Iasi, Romania.
Marinca MV; Oncology Department, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Alexa-Stratulat T; Medical Oncology Department, Regional Institute of Oncology, 700483 Iasi, Romania.

J Pers Med ; 12(10)2022 Oct 08.

Article en En | MEDLINE | ID: mdl-36294809

Palabras clave

adjuvant temozolomide; chemotherapy; glioblastoma; number of cycles; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google